phropathy, and blockade of the RAS by ramipril may confer Long-term treatment with ramipril attenuates renal osteoponrenoprotection by decreasing OPN expression in non-insulintin expression in diabetic rats. dependent diabetic nephropathy. Background. Osteopontin (OPN) mediates progressive renal injury in various renal diseases by attracting macrophages, and its expression is regulated by the renin-angiotensin system (RAS). We studied the association between OPN expression and Diabetic nephropathy is characterized by a progressive tubulointerstitial injury, and investigated the effect of ramipril accumulation of extracellular matrix components in the on OPN expression in an animal model of non-insulin-dependent diabetes mellitus (NIDDM): Otsuka Long-Evans Tokuglomerular mesangium and tubular interstitium, which shima Fatty (OLETF) rats. eventually leads to proteinuria and renal failure [1, 2]. It
phropathy, and blockade of the RAS by ramipril may confer Long-term treatment with ramipril attenuates renal osteoponrenoprotection by decreasing OPN expression in non-insulintin expression in diabetic rats. dependent diabetic nephropathy. Background. Osteopontin (OPN) mediates progressive renal injury in various renal diseases by attracting macrophages, and its expression is regulated by the renin-angiotensin system (RAS). We studied the association between OPN expression and Diabetic nephropathy is characterized by a progressive tubulointerstitial injury, and investigated the effect of ramipril accumulation of extracellular matrix components in the on OPN expression in an animal model of non-insulin-dependent diabetes mellitus (NIDDM): Otsuka Long-Evans Tokuglomerular mesangium and tubular interstitium, which shima Fatty (OLETF) rats. eventually leads to proteinuria and renal failure [1, 2] . It Methods. Control (Long-Evans Tokushima Otsuka, LETO) is generally accepted that tubulointerstitial injury, along and diabetic (OLETF) rats were treated with ramipril (3 mg/kg with glomerulosclerosis, is a major feature and an imporin drinking water) or vehicle for nine months, starting at 20 weeks of age. Systolic blood pressure, body weight, urinary pro-tant predictor of renal dysfunction in diabetic nephropatein excretion and oral glucose tolerance tests (OGTT) were thy [3, 4] . The mechanisms underlying the evolution of monitored periodically. Renal function, histology (glomerulodiabetic nephropathy are extremely complex, and sevsclerosis, tubulointerstitial fibrosis, and ED-1-positive cells as eral mediators have been implicated. Of these, chemoa measure of macrophage infiltration), and expressions of OPN attractants and infiltrated macrophages have been proand transforming growth factor-␤1 (TGF-␤1) were evaluated at the end of the study. posed to be important players [5] [6] [7] .
Results. Compared with the LETO rats, OLETF rats showed Osteopontin (OPN) is a molecule that mediates cell declines in creatinine clearance rate, increases in urinary proadhesion and migration and functions by binding avidly to tein excretion and systolic blood pressure, and development a number of ligands, including ␣ v ␤ 3 integrin, CD44, collaof glomerulosclerosis, tubulointerstitial fibrosis, and inflammatory cell infiltration (all P Ͻ 0.05). Blocking angiotensin II gen type I, and fibronectin [8, 9] . Many types of cells, inwith ramipril significantly improved all of these parameters cluding osteoclasts, some epithelial cells, macrophages, (all P Ͻ 0.01). At the molecular level, expressions of OPN T cells, smooth muscle cells, and some tumors [10] [11] [12] [13] [14] [15] , exand TGF-␤1 were up-regulated in the OLETF rats, and were press OPN in a constitutive or inducible fashion. A funcmarkedly suppressed following ramipril treatment. The sites of strong OPN mRNA and protein expressions were localized tional role for OPN with respect to attracting macroto areas of renal injury. Of note, the expression of OPN mRNA phages has been recently documented in vivo and in was strongly correlated with the number of ED-1-positive cells vitro [16, 17] . The up-regulation of OPN expression is (r ϭ 0.560, P ϭ 0.01) and the tubulointerstitial fibrosis score also closely associated with macrophage influx in several (r ϭ 0.500, P Ͻ 0.05). models of kidney disease [18] [19] [20] . Moreover, the extent Conclusions. Up-regulation of OPN expression may play a role in tubulointerstitial injury associated with diabetic neof up-regulation of OPN expression in tubules correlates with the degree of macrophage accumulation and the magnitude of tubulointerstitial fibrosis and renal dysplay a pathogenic role in the late stages of tubulointerstitial injury of diabetic nephropathy, and that its expres- 2003 by the International Society of Nephrology sion is influenced by the renin-angiotensin system (RAS). before and 30, 60, 90, and 120 minutes after the OGTT from the tail vein as previously described [25] . All ani-To test this hypothesis, we examined the role of the RAS in regulating OPN by administering the angiotensin-con-mals were caged individually for 24-hour urine collection at before and three, six, and nine months. Urinary pro-verting enzyme (ACE) inhibitor ramipril in a newly established animal model: Otsuka Long-Evans Tokushima tein excretion (U prot E) was estimated using the sulfosalicylic acid method. Blood samples were also obtained Fatty (OLETF) rats, a strain showing spontaneous noninsulin-dependent diabetes mellitus (NIDDM) [22] [23] [24] [25] .
before euthanizing the rats at nine months. The creatinine clearance rate (C Cr ) was calculated using a standard Using this animal model, we clearly demonstrate an association between the RAS and OPN in the development formula. of type II diabetic nephropathy.
Histology
The kidney specimens were fixed in Periodate-lysine-METHODS paraformaldehyde (PLP) solution and embedded in wax.
Animals and drugs
Four-micrometer sections were processed and stained with periodic acid-Schiff (PAS) reagent and Masson trichrome. Age-matched male OLETF and Long-Evans Tokushima Otsuka (LETO) rats were provided by Otsuka Glomerulosclerosis was assessed on PAS-stained sections using a semiquantitative score from 0 to 4 [26] : grade Pharmaceutical Tokushima Research Institute (Tokushima, Japan). Animals were housed in cages (Nalge Co., 0 ϭ no sclerosis; grade 1 ϭ sclerosis up to 25% of glomeruli; grade 2 ϭ sclerosis from 25% to 50% of glomeruli; Rochester, NY, USA) under a temperature and lightcontrolled environment, and allowed free access to stan-grade 3 ϭ sclerosis from 50% to 75% of glomeruli; grade 4 ϭ sclerosis more than 75% of glomeruli. More than dard laboratory chow (Teklad Premier) and tap water. Ramipril (Hoechst AG, Frankfurt, Germany) was admin-50 glomeruli were analyzed for each rat. For evaluating tubulointerstitial fibrosis, a minimum of 20 fields per istered in drinking water at a daily dose of 3 mg/kg [48] . section (trichrome stained) was evaluated using a color Research design image analyzer (Mustek Paragon 800 SP, Macintosh PowerPC 7100 running NIH image V. 1.5 software). The Forty rats at 20 weeks of age were assigned randomly into four subgroups and treated daily with ramipril or extent of tubulointerstitial fibrosis was evaluated by counting the percentage of areas injured per field of vehicle for nine months:
cortex. Scores from 0 to 3 were used: 0 ϭ normal interstitium; 0.5 ϭ Ͻ5% of areas injured; 1 ϭ 5 to 15% of areas (1) LETO controls (L ϩ C, N ϭ 10) received vehicle (drinking water); injured; 1.5 ϭ 16 to 25% of areas injured; 2 ϭ 26 to 35% of areas injured; 2.5 ϭ 36 to 45% of areas injured; 3 ϭ (2) LETO ramipril-treated rats (L ϩ R, N ϭ 10) received ramipril (3 mg/kg in drinking water); Ͼ45% of areas injured [27] . Histological analyses were performed in randomly selected cortical fields of sections (3) OLETF controls (OL ϩ C, N ϭ 10) received vehicle (drinking water); by a pathologist who was blinded to the identity of the treatment groups. (4) OLETO ramipril-treated rats (OL ϩ R, N ϭ 10) received ramipril (3 mg/kg in drinking water).
Northern blots of osteopontin and TGF-␤1
A 1 kb cRNA probe was generated from 2B7 cDNA At the end of the experiment, all animals were euthanized with ketamine, and kidney tissues were removed clone of rat smooth muscle OPN [11] . Sense and antisense cRNA probe were labeled with digoxigenin (DIG)-rapidly for morphological and molecular examinations.
The experimental protocol and care of animals were UTP using a T7 RNA polymerase kit (Boehringer Mannheim GmbH, Mannheim, Germany). Probes were pre-approved by the Animal Care Committee of the Catholic University of Korea. cipitated and incorporation of DIG was determined by dot blotting. Northern blotting was performed as pre-Functional protocol viously reported [28] . Briefly, kidney cortex was homogenized. Total RNA was extracted using the RNAzol re-Body weight was recorded periodically for each rat. Systolic blood pressure (SBP) was measured in conscious agent (Tel-Test, Inc., TX, USA), and 20 g samples were denatured with glyoxal and dimethylsulphoxide, size frac-rats every three months using plethysmography using a tail manometer-tachometer system (BP-2000; Visitech tionated on 1.2% agarose gels and capillary blotted onto positively-charged nylon membranes (Boehringer Mann-Systems, Apex, NC, USA); at least three readings for each rat were averaged. An oral glucose tolerance test heim). Membranes were hybridized overnight at 68ЊC or 42ЊC with DIG-labeled cRNA (or 32 P labeled cDNA (OGTT) was performed on rats fasted for 16 hours at the start and three and nine months. Glucose (2 g) solution probes) in a DIG wash and Block Buffer Set solution (Boehringer Mannheim). Following hybridization, mem-was given orally to rats, and blood samples were collected branes were washed finally in [0.1 ϫ standard saline citrate ilar to that for OPN. The numbers of ED-1 positive cells (SSC)]/0.1% sodium dodecyl sulfate (SDS) at 68ЊC or were counted in at least 20 fields of cortex per section (0.2 ϫ SSC)/0.1% SDS at 42ЊC. Bound probes were under ϫ200 magnification. detected using sheet anti-DIG antibody (Fab) conjugated Statistical analysis with alkaline phosphatase (Boehringer Mannheim) and development with CSPD-star enhanced chemilumines-Data are presented as mean Ϯ SEM. Comparisons cence (Boehringer Mannheim). The densitometry analybetween groups were performed by one-way ANOVA sis was performed using the NIH ImagePC program.
with post hoc Bonferroni test or repeated measures anal-Three determinations for each band were averaged and ysis of variance (ANOVA; time course). The Pearson referenced to glyceraldehyde-3-phosphate dehydrogesingle-correlation coefficient was used to compare osteonase (GAPDH; %). Data are expressed as mean Ϯ SEM.
pontin mRNA expression with ED-1 positive cells and tubulointerstitial fibrosis score. Statistical significance In situ hybridization was accepted when P Ͻ 0.05. In situ hybridization was performed on wax-embedded sections using a microwave-based protocol as previously RESULTS described [28] . After dewaxing, sections were treated with a microwave oven for 2 ϫ 5 minutes, incubated Functional findings with 0.2 mol/L HCl for 15 minutes, followed by 1%
As shown in Figure 1A , the OLETF rats became obese Triton X-100 for 15 minutes, and then digested for 20 from the initiation of treatment and throughout the exminutes with 10 g/mL proteinase-K at 37ЊC (Boehperimental period compared with LETO control rats, ringer Mannheim). Sections were washed in 2 ϫ SSC, although the body weights of LETO rats also increased prehybridized, and then hybridized with 0.3 ng/L DIGgradually with age. Ramipril treatment did not influence labeled sense or antisense OPN cRNA probe overnight body weights in either treatment groups. OLETF rats at 37ЊC in a hybridization buffer containing 50% deionhad higher SBP levels than LETO rats at the start of the ized formamide, 4 ϫ SSC, 2 ϫ Denhardt's solution, experiment (131 Ϯ 2 vs. 123 Ϯ 2 mm Hg, P Ͻ 0.05; Fig. 1B ). 1 mg/mL salmon sperm DNA, and 1 mg/mL yeast tRNA.
Blockade of angiotensin II (Ang II) with ramipril mark-Sections were washed finally in 0.1 ϫ SSC at 37ЊC, and edly lowered the SBP of OLETF rats throughout treatthe hybridized probe was detected using sheep anti-DIG ment versus the untreated OLETF rats (P Ͻ 0.05). antibody (Fab) conjugated with alkaline phosphatase
The C Cr was significantly lower in OLETF controls and color development with NBT/ X-phosphate (Boehthan in LETO controls (0.16 Ϯ 0.01 vs. 0.26 Ϯ 0.02 mL/ ringer Mannheim). No signal was seen with the sense min per 100, P Ͻ 0.05), but ramipril treatment mainriboprobe labeled to the same specific activity.
tained the C Cr of OLETF rats to levels similar to those of LETO rats (Fig. 1C ). Levels of UPE were higher in Immunohistochemistry OLETF rats than in LETO rats at the initiation of study After dewaxing, sections were incubated with 0.5% (30.3 Ϯ 3.1 vs. 17.9 Ϯ 1.1 mg/24 h, P Ͻ 0.05), and in-Triton X 100/PBS solution for 30 minutes and washed creased progressively throughout the treatment intervals with phosphate-buffered saline (PBS) three times. Non- (Fig. 1D ). Ramipril treatment decreased the U prot E of specific binding sites were blocked with normal horse OLETF rats at three months compared with the unserum diluted 1:10 in 0.3% bovine serum albumin (BSA) treated OLETF rats (31.8 Ϯ 1.3 vs. 48.3 Ϯ 4.8 mg/24 h, for 30 to 60 minutes, and then incubated for two hours P Ͻ 0.01). at 4ЊC in mouse antiserum against OPN (MPIIIB10, ob- Figure 2 shows plasma glucose responses in the treattained from the Developmental Studies Hybridoma ment groups at zero, three, and nine months. Plasma Bank, University of Iowa, Iowa City, IA, USA) diluted OGTT responses of LETO rats, whether vehicle-or ram-1:1000 in a humid environment. After rinsing in Trisipril-treated, were within the normal ranges at each time buffered saline (TBS), sections were incubated in peroxipoint ( Fig. 2A ). There were no initial differences in the dase-conjugated rabbit anti-mouse IgG (Amersham Phar-OGTT responses between LETO and OLETF rats. macia Biotech, Piscataway, NJ, USA), for 30 minutes.
However, at three months, both vehicle-and ramipril-For coloration, sections were incubated with a mixture treated OLETF rats showed diabetes, as indicated by a of 0.05% 3,3Ј-diaminobenzidine containing 0.01% H 2 O 2 plasma glucose response in the OGTT (Fig. 2B) , and at room temperature until a brown color was visible, the plasma glucose responses in OLETF rats were sigwashed with TBS, counterstained with hematoxylin and nificantly higher than in LETO rats at nine months (P Ͻ examined under light microscopy. The procedure of im-0.05; Fig. 2C ). Ramipril treatment did not affect the munostaining for ED-1 (Serotec, Inc., Indianapolis, IN, plasma glucose concentrations of LETO and OLETF USA) and transforming growth factor-␤1 (TGF-␤1; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) was sim-rats in the OGTT at any time point. 
Effects of ramipril on glomerulosclerosis and prominent in the cortical regions of the kidneys of tubulointerstitial fibrosis
OLETF controls versus the LETO controls (1.90 Ϯ 0.24 vs. 0.25 Ϯ 0.08, respectively; P Ͻ 0.001). However, this OLETF rats showed typical histological features of lesion was significantly attenuated following blockade glomerulopathy, characterized by thickening of the baseof Ang II with ramipril (1.00 Ϯ 0.17 vs. 1.90 Ϯ 0.24, ment membrane, arteriolar hyalinosis, and nodular or respectively; P ϭ 0.002). sclerotic lesions (Fig. 3) . Tubulointerstitial fibrosis featured matrix-rich expansion of the interstitium with dis-Effects of ramipril on osteopontin mRNA and tortion and collapse of the tubules, and thickening of the protein expression tubular basement membranes (Fig. 4) . Focal macrophage Northern blot analysis of the kidney cortex demoninfiltration was observed also within the tubular interstistrated a dramatic increase in OPN mRNA in OLETF tium. On our semiquantitative scoring system, OLETF controls versus LETO controls by the end of the study controls showed moderate glomerulosclerosis compared (705 Ϯ 49 vs. 107 Ϯ 3%, P Ͻ 0.001; Fig. 5A ), but this with the LETO controls (2.7 Ϯ 0.3 vs. 0.4 Ϯ 0.2, P Ͻ up-regulation of OPN mRNA expression was markedly 0.001; Fig. 3 ). Ramipril treatment significantly delayed decreased in response to ramipril treatment (298 Ϯ 35 the development of glomerulosclerosis in OLETF rats vs. 705 Ϯ 49%, P Ͻ 0.005). To localize OPN mRNA and compared with the untreated OLETF rats (1.5 Ϯ 0.2 vs. 2.7 Ϯ 0.3, P ϭ 0.004). Tubulointerstitial fibrosis was protein, in situ hybridization and immunohistochemistry were performed (Fig. 6 ). Consistent with previous re-were significantly suppressed. No consistent differences in OPN mRNA and protein levels between OLETF con-ports [21, 28] , in the LETO rats, a much higher level of OPN expression was observed in the medulla (data not trols and OLETF-ramipril treated rats were observed in medullary regions (data not shown). shown), which was confined to the tubular epithelium, collecting ducts and uroepithelial lining cells. However, Effects of ramipril on TGF-␤1 mRNA and most cortical structures were negative for OPN mRNA protein expression and protein, although occasional weak expression was detected in some tubular epithelial cells of the distal As shown in Figure 5B , TGF-␤1 mRNA expression tubules and parietal epithelial cells of Bowman capsules was higher in OLETF controls than in LETO rats (507 Ϯ and the renal cortex. In contrast, the levels of OPN 81 vs. 106 Ϯ 8%, P Ͻ 0.001) and this was abrogated by mRNA and protein in OLETF controls were dramatiramipril treatment (240 Ϯ 38 vs. 507 Ϯ 81%, P ϭ 0.001). cally elevated in tubular epithelium and Bowman's cap-Consistently, TGF-␤1 protein expression, as detected sule cells. The most striking changes were seen in the by immunohistochemistry, was rarely observed in the renal cortex (Fig. 6, C1 and C2) , which normally exkidneys of LETO rats, whereas its immunoreactivity was pressed very little constitutive OPN. Interestingly, the markedly increased in the OLETF controls and was sites of strong OPN mRNA and protein expressions were mainly localized to areas of cortical tubule and interstitium ( Fig. 7) . With ramipril treatment, immunoreactivity localized to areas of severe tissue damage, including atrophied tubules. In OLETF rats treated with ramipril for of TGF-␤1 in the OLETF controls was reduced when compared with the untreated OLETF rats. nine months, both OPN mRNA and protein expressions ramipril treated rats. OLETF controls showed renal tubular atrophy, inflammatory cell infiltration, and extracellular matrix deposition, whereas blockade of angiotensin II with ramipril significantly attenuated these structural changes. #P Ͻ 0.001 vs. LETO controls; ##P ϭ 0.002 vs. OLETF controls. Masson trichrome staining, original magnification
Effects of ramipril on macrophage infiltration
ϫ100.
Macrophages, as detected by immunohistochemical staining for ED-1, were rarely observed within the tubular interstitium of LETO rats, but their numbers were ED-1 positive cells (r ϭ 0.560, P ϭ 0.01) and the tubulosignificantly higher in the OLETF controls (2.6 Ϯ 0.5 vs.
interstitial fibrosis score (r ϭ 0.500, P ϭ 0.025). 21.0 Ϯ 2.8, respectively; P Ͻ 0.001), especially in fibrotic lesions (Fig. 8) . Ramipril markedly decreased the number of ED-1 positive cells in the OLETF controls (9.6 Ϯ DISCUSSION 1.0 vs. 21.0 Ϯ 2.8, respectively; P Ͻ 0.001).
Our results clearly demonstrate that OPN mRNA and protein expressions are markedly up-regulated in OLETF Association between osteopontin expression and diabetic rat kidneys, in association with macrophage inthe number of ED-1 positive cells and flux and tubulointerstitial fibrosis. With ramipril treattubulointerstitial fibrosis ment, OPN expression was significantly suppressed, and The relationship between OPN mRNA expression and this coincided with reductions in macrophage infiltration macrophage accumulation and tubulointerstitial fibrosis and tubulointerstitial fibrosis. These findings suggest that was analyzed in the OLETF rats (N ϭ 20; Fig. 9 ). OPN the up-regulation of OPN may be responsible for tubulointerstitial inflammation and fibrotic formation, and that mRNA expression correlated well with the numbers of OPN expression is regulated by the RAS in diabetic sion is regulated by the RAS, and that it is associated with tubulointerstitial injury [21, 28] . Ang II has been nephropathy during late stages.
Osteopontin is a potent chemotactic and adhesive fac-shown to up-regulate OPN expression in proximal tubular cells in vitro [38, 39] , and Ang II infusion into rats tor for macrophages [8, 9, 17] , and there is overwhelming evidence that the up-regulation of tubular OPN expres-induces OPN expression and the accumulation of tubulointerstitial macrophages and fibrosis [40] . In addition, sion is strongly associated with macrophage infiltration subsequent to tubulointerstitial injury in experimental the blockade of Ang II by using either angiotensin-converting enzyme (ACE) inhibitors or Ang II type 1 (AT1) studies [18] [19] [20] [21] 29] and in human patients with kidney diseases [30] [31] [32] . This concept is confirmed by studies receptor antagonists may blunt the OPN expression accompanying reduced macrophage influx and tubulointer-using OPN-gene knockout mice [33] , and antisense-treated or anti-OPN antibody-treated animals [34] [35] [36] [37] , demon-stitial injury [21, 28] . The current study and previous reports strongly implicate a role for Ang II in the up-strating a marked reduction in macrophage influx and renal impairment. The results of the present study show regulation of OPN in this model, and ramipril may act in a renoprotective manner by suppressing inflammatory that tubular OPN expressions, as detected by Northern blots, in situ hybridization, and immunohistochemistry, cytokine OPN expression. The mechanism by which Ang II stimulates OPN ex-was dramatically up-regulated in OLETF rats in parallel with the number of ED-1 positive cells, as well as with pression in renal tubules in this model may be direct or indirect. Ang II may act directly to stimulate tubular the development of tubulointerstitial fibrosis. Thus, increased OPN expression may be involved in the develop-expression of OPN [38] [39] [40] . However, a number of indirect mechanisms also should be considered. First, sys-ment of tubulointerstitial inflammation associated with diabetic nephropathy in OLETF rats.
temic hypertension in this model may be involved in the up-regulation of OPN, as other antihypertensive drugs It is interesting that the up-regulation of OPN expression in diabetic rat kidneys was significantly suppressed also suppress OPN expression [41] . Second, Ang II is able to induce TGF-␤ expression [42] , a key profibrotic by blocking the RAS with ramipril. This reduction in OPN expression correlated well with the decreased num-cytokine involved in the pathogenesis of diabetic nephropathy [24, 43] , or proteinuria [44] . Both of these ber of ED-1 positive cells (r ϭ 0.560, P ϭ 0.01) and with levels of tubulointerstitial fibrosis (r ϭ 0.500, P Ͻ 0.05).
pathways have been shown to up-regulate OPN expression [45, 46] . Third, high glucose enhances Ang II genera-This is consistent with previous reports that OPN expres- A and B) . In the OLETF controls, however, their exprespathways may account for the progression of renal injury sion was markedly increased (C ). With ramipril treatment, these increased OPN mRNA and protein expressions were abrogated (D). Original magbetween insulin-dependent (IDDM) and non-insulinnification ϫ100. dependent (NIDDM) diabetes mellitus. Further studies are required to resolve this issue.
One of the considerations in interpreting our study is the duration of study. The prolonged duration of this extion in primary cultures of rat mesangial cells, which in periment (nine months) in such relatively short-lived aniturn stimulates TGF-␤1 production [47], leading us to mals may create a model of renal disease of age, in addipostulate an interaction between Ang II and high glucose tion to that of simple diabetic nephropathy. Age-related status. In the present study, blocking Ang II activity renal disease may mimic that of diabetic nephropathy, markedly abrogated the up-regulation of renal TGF-␤1 in which renal insufficiency, glomerulosclerosis and tuexpressions, proteinuria, and systolic blood pressure. bulointerstitial fibrosis as well as up-regulation of OPN Therefore, OPN expression must be regulated by several expression and macrophage infiltration are observed factors (Ang II, TGF-␤1, proteinuria, systemic hyperten-[50, 51]. Therefore, there is a possibility that changes in sion, high glucose), and Ang II must play a critical role renal function, histology, and OPN expression in this in the expression of OPN in this model. model are associated with aging nephropathy along with Our study revealed that OPN expression increased in rat kidneys with type II diabetes mellitus (DM), but the diabetic nephropathy. In addition, blockade of the RAS and P Ͻ 0.05.
